Vitamin D and its association with symptom severity in knee osteoarthritis: a cross sectional study at a national referral hospital in Uganda

Fiona Namutebi, James Kayima, Mark Kaddumukasa, Fiona Namutebi, James Kayima, Mark Kaddumukasa

Abstract

Background: Vitamin D deficiency is highly prevalent among patients with osteoarthritis. It is associated with joint pain, stiffness and worse physical function. Whether vitamin D deficiency is associated with osteoarthritis is controversial. We investigated serum vitamin D levels and its association with symptom severity in patients with knee osteoarthritis.

Methods: Between January 2020 to March and May 2020, we conducted a cross sectional study at a national referral hospital in Uganda. Using the American College of Rheumatology clinical criteria, 107 consenting adults were diagnosed with knee osteoarthritis. A questionnaire captured patient demographics and clinical characteristics. Joint pain, stiffness and physical function severity were assessed and graded based on the Western Ontario and McMaster Universities Arthritis Index (WOMAC). We determined serum vitamin D levels by electrochemilumniscence immunoassay. The data were analysed and adjusted for age, sex, education, occupation, family history, body mass index (BMI) and calcium supplementation.

Results: Of the 107 patients, 92 (86%) patients were females, mean (SD) age was 58.1 (12.6) years. Nearly 65% of the patients had suboptimal serum vitamin D levels < 30 ng/ml. The median (Q1, Q3) WOMAC joint scores were as follows: pain 8.0 (5, 11), stiffness 1 (0, 2), physical function 29.0 (16, 41) and total WOMAC 39.0 (21, 54). Spearman correlations between serum vitamin D levels with symptom severity were as follows: joint pain (r = 0.18, p = 0.06), stiffness (r = 0.13, p = 0.17), physical function (r = 0.09, p = 0.36) and total WOMAC (r = 0.13, p = 0.19).

Conclusion: Serum vitamin D levels are not associated with joint pain, stiffness and physical function severity. Older age and higher BMI are associated with vitamin D deficiency in patients with knee osteoarthritis attending a national referral hospital rheumatology clinic in Uganda. Suboptimal vitamin D is an independent risk factor for total mortality in the general population. Clinical guidelines and further studies to determine age and BMI ranges required for vitamin D screening are needed in patients with osteoarthritis in Uganda. Patients are advised to keep a normal BMI.

Keywords: Osteoarthritis; Uganda; Vitamin D levels.

Conflict of interest statement

The authors declare that they have no competing interests.

© 2021. The Author(s).

Figures

Fig. 1
Fig. 1
Study flow diagram

References

    1. Laslett LL, Quinn S, Burgess JR, Parameswaran V, Winzenberg TM, Jones G, et al. Moderate vitamin D deficiency is associated with changes in knee and hip pain in older adults: a 5-year longitudinal study. Ann. Rheumatic Dis. 2013:annrheumdis-2012-202831.
    1. Muraki S, Dennison E, Jameson K, Boucher B, Akune T, Yoshimura N, et al. Association of vitamin D status with knee pain and radiographic knee osteoarthritis. Osteoarthr Cartil. 2011;19(11):1301–1306. doi: 10.1016/j.joca.2011.07.017.
    1. Sohl E, Van Schoor N, De Jongh R, Visser M, Deeg D, Lips P. Vitamin D status is associated with functional limitations and functional decline in older individuals. J Clin Endocrinol Metab. 2013;98(9):E1483–E1490. doi: 10.1210/jc.2013-1698.
    1. McAlindon TE, Felson DT, Zhang Y, Hannan MT, Aliabadi P, Weissman B, et al. Relation of dietary intake and serum levels of vitamin D to progression of osteoarthritis of the knee among participants in the Framingham Study. Ann Intern Med. 1996;125(5):353–359. doi: 10.7326/0003-4819-125-5-199609010-00001.
    1. Liu-Bryan R, Terkeltaub R. Emerging regulators of the inflammatory process in osteoarthritis. Nat Rev Rheumatol. 2015;11(1):35–44. doi: 10.1038/nrrheum.2014.162.
    1. Guccione AA, Felson DT, Anderson JJ, Anthony JM, Zhang Y, Wilson P, et al. The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health. 1994;84(3):351–358. doi: 10.2105/AJPH.84.3.351.
    1. Neogi T. The epidemiology and impact of pain in osteoarthritis. Osteoarthr Cartil. 2013;21(9):1145–1153. doi: 10.1016/j.joca.2013.03.018.
    1. Chronic Diseases and Health Promotion [Internet]. .
    1. Cakar M, Ayanoglu S, Cabuk H, Seyran M, Dedeoglu SS, Gurbuz H. Association between vitamin D concentrations and knee pain in patients with osteoarthritis. PeerJ. 2018;6:e4670. doi: 10.7717/peerj.4670.
    1. Sanghi D, Mishra A, Sharma AC, Singh A, Natu S, Agarwal S, et al. Does vitamin D improve osteoarthritis of the knee: a randomized controlled pilot trial. Clin Orthop Relat Res. 2013;471(11):3556–3562. doi: 10.1007/s11999-013-3201-6.
    1. Arden NK, Cro S, Sheard S, Doré CJ, Bara A, Tebbs SA, et al. The effect of vitamin D supplementation on knee osteoarthritis, the VIDEO study: a randomised controlled trial. Osteoarthr Cartil. 2016;24(11):1858–1866. doi: 10.1016/j.joca.2016.05.020.
    1. Jin X, Jones G, Cicuttini F, Wluka A, Zhu Z, Han W, et al. Effect of vitamin D supplementation on tibial cartilage volume and knee pain among patients with symptomatic knee osteoarthritis: a randomized clinical trial. JAMA. 2016;315(10):1005–1013. doi: 10.1001/jama.2016.1961.
    1. McAlindon T, LaValley M, Schneider E, Nuite M, Lee JY, Price LL, et al. Effect of vitamin D supplementation on progression of knee pain and cartilage volume loss in patients with symptomatic osteoarthritis: a randomized controlled trial. JAMA. 2013;309(2):155–162. doi: 10.1001/jama.2012.164487.
    1. Alsubiaee KM. The effects of vitamin D supplementation in patients with knee osteoarthritis: uncontrolled open label clinical trial. J Arthritis. 2016;5:6. doi: 10.4172/2167-7921.1000222.
    1. Nansera D, Graziano F, Friedman D, Bobbs M, Jones A, Hansen K. Vitamin D and calcium levels in Ugandan adults with human immunodeficiency virus and tuberculosis. Int J Tuberc Lung Dis. 2011;15(11):1522–1528. doi: 10.5588/ijtld.10.0701.
    1. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum Off J Am Coll Rheumatol. 1986;29(8):1039–1049. doi: 10.1002/art.1780290816.
    1. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–1930. doi: 10.1210/jc.2011-0385.
    1. Bolognese JA, Schnitzer T, Ehrich E. Response relationship of VAS and Likert scales in osteoarthritis efficacy measurement. Osteoarthr Cartil. 2003;11(7):499–507. doi: 10.1016/S1063-4584(03)00082-7.
    1. Allain TJ, Beresford PA, Newman JH, Swinkels A. Vitamin D levels in patients undergoing knee arthroplasty: does vitamin D status effect postoperative outcomes? e-SPEN Eur e-J Clin Nutr Metabol. 2008;3(1):e17–e21. doi: 10.1016/j.eclnm.2007.10.002.
    1. Chlebowski RT, Johnson KC, Lane D, Pettinger M, Kooperberg CL, Wactawski-Wende J, et al. 25-Hydroxyvitamin D concentration, vitamin D intake and joint symptoms in postmenopausal women. Maturitas. 2011;68(1):73–78. doi: 10.1016/j.maturitas.2010.10.006.
    1. Başkan BM, Yurdakul FG, Aydın E, Sivas F, Bodur H. Effect of vitamin D levels on radiographic knee osteoarthritis and functional status. Turk J Phys Med Rehabil. 2018;64(1):1.
    1. Al-Jarallah KF, Shehab D, Al-Awadhi A, Nahar I, Haider MZ, Moussa MA. Are 25 (OH) D levels related to the severity of knee osteoarthritis and function? Med Princ Pract. 2012;21(1):74–78. doi: 10.1159/000330025.
    1. Clemens T, Henderson S, Adams J, Holick M. Increased skin pigment reduces the capacity of skin to synthesise vitamin D3. The Lancet. 1982;319(8263):74–76. doi: 10.1016/S0140-6736(82)90214-8.
    1. Hintzpeter B, Scheidt-Nave C, Müller MJ, Schenk L, Mensink GB. Higher prevalence of vitamin D deficiency is associated with immigrant background among children and adolescents in Germany. J Nutr. 2008;138(8):1482–1490. doi: 10.1093/jn/138.8.1482.
    1. Zhou C, Assem M, Tay JC, Watkins PB, Blumberg B, Schuetz EG, et al. Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia. J Clin Investig. 2006;116(6):1703–1712. doi: 10.1172/JCI27793.
    1. Melamed ML, Michos ED, Post W, Astor B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008;168(15):1629–1637. doi: 10.1001/archinte.168.15.1629.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe